deImpulses from modern blood purification
Immunotherapy for cancer is now considered one of the most promising developments in modern oncology. Instead of relying exclusively on chemotherapy or radiotherapy, cancer immunotherapy uses the body’s own defenses to specifically combat tumor cells. But what happens if the immune system is already weakened or the cancer cells have managed to evade the attack? This is precisely where VitaSangius comes in – with an integrative concept that can provide targeted support for cancer immunotherapy.
Why the immune system takes center stage
Cancer immunotherapy is based on a simple but paradigm-shifting principle: the body should learn to recognize and destroy tumour cells itself. However, certain conditions must be met for this to happen. An immune system that is overloaded, weakened or blocked by chronic inflammation cannot perform this task adequately.
Despite immunotherapy for cancer, many patients experience a relapse or do not respond sufficiently to the therapy. There are many reasons for this: exposure to harmful substances, chronic inflammatory processes or excessive immune activity can disrupt the balance. Frequent immunotherapy side effects such as exhaustion, skin reactions or inflammation can also increase the overall burden.
How VitaSangius accompanies immunotherapy for cancer
VitaSangius offers a medically sound concept to supplement classic cancer immunotherapy, which focuses on root cause research, relief and targeted support of the immune system. The focus is on state-of-the-art extracorporeal blood purification procedures such as:
-
- Double filtration plasmapheresis (DFPP): This form of blood washing can remove pro-inflammatory substances, autoantibodies or metabolic toxins from the plasma – an important prerequisite for making immunotherapy for cancer more effective and reducing immunotherapy side effects.
-
- Hemoperfusion: Particularly suitable in cases of high toxic load. This method filters specific toxic molecules and helps to restore the body’s regulatory capacity – which can have a particularly supportive effect in immunotherapy for metastases.
Hemoperfusion: targeted mitigation of the side effects of chemotherapy
In addition to immunotherapy, many patients continue to receive chemotherapy – often with considerable stress on the entire organism. This is precisely where hemoperfusion can make a valuable contribution: by specifically removing circulating toxins, cell degradation products and inflammation-promoting substances, it can help to alleviate typical side effects of chemotherapy such as nausea, exhaustion or neurological complaints.
At VitaSangius, haemoperfusion is therefore not only used to support immunotherapy for cancer, but also to improve the tolerability of classic chemotherapy. The aim is to reduce the overall burden on the body and give the immune system more room for regeneration.
Infusion therapies: High-dose micronutrients to support immunotherapy for cancer
VitaSangius also uses targeted infusion therapies to strengthen the body’s own defenses and effectively accompany immunotherapy for cancer. High-dose vitamin C has an antioxidant effect, supports mitochondrial function and can promote cell regeneration – an advantage, especially when immunotherapy side effects impair general well-being. Another key component is the curcumin infusion, which is a valuable addition to integrative cancer therapy due to its diverse mechanisms of action.
Curcumin infusion: Natural support for the immune system in cancer therapy
Curcumin, the bioactive component of turmeric root, has shown promising properties in preclinical studies in the context of cancer immunotherapy. It has an anti-inflammatory and antioxidant effect and can promote apoptosis (programmed cell death) in cancer cells. In addition, curcumin modulates various signaling pathways involved in tumor development and can increase the sensitivity of cancer cells to chemotherapy and radiation – an aspect that potentially increases the chances of immunotherapy success.
As curcumin is poorly bioavailable orally, VitaSangius administers it in the form of infusions. This enables a higher concentration in the bloodstream and a direct effect on the tumor environment. The infusions are individually dosed and used in combination with other therapeutic procedures to ensure the best possible support for immunotherapy for cancer – including immunotherapy for metastases or immunotherapy for lung cancer.
Individualized support instead of standard programs
At VitaSangius, no treatment follows a rigid standard protocol. Every person is unique – and so is their illness. Our patients usually come to us with a confirmed diagnosis and ongoing oncological therapy. Our task is to provide meaningful support for this therapy through individually tailored measures. We start with comprehensive diagnostics: heavy metal contamination, oxidative stress, micronutrient deficiencies and immunological imbalances are examined. On this basis, we develop a personalized concept that is specifically designed to relieve the body, strengthen the immune system and provide the best possible support for ongoing cancer immunotherapy.
Immunotherapy Life expectancy: New perspectives for patients
A central aspect that concerns many patients is the question of immunotherapy life expectancy. Clinical studies and practical experience show: When immunotherapy for cancer takes effect, it can significantly improve life expectancy – even in
Situations in which conventional therapies have been exhausted. Targeted activation of the immune system not only combats tumor cells, but also reduces the risk of relapse. In combination with complementary procedures such as blood purification and infusion therapies, as used at VitaSangius, the chances of long-term stabilization and improved quality of life and thus life expectancy can increase significantly.
Immunotherapy chances of success: when the body actively cooperates
The chances of immunotherapy success depend largely on how well the immune system responds to the treatment. Studies have shown that impressive successes can be achieved, particularly with immunologically active tumor types such as malignant melanoma or certain lymphomas. However, it is crucial that the immune system is able to absorb and implement the therapeutic impulses. This is precisely where VitaSangius comes in: By specifically relieving the immune system, regulating the internal environment and supplying essential micronutrients, the chances of immunotherapy success can often be improved – especially in patients who were previously considered resistant to therapy.
Immunotherapy for lung cancer: individualized support in a difficult situation
Immunotherapy for lung cancer represents one of the greatest challenges in modern oncology – not least because of the often late diagnosis and complex tumor biology. Nevertheless, promising therapy concepts have been developed in recent years, focusing primarily on checkpoint inhibitors.
In addition to conventional medical treatment, VitaSangius can help to stabilize the effects of immunotherapy for lung cancer and mitigate side effects. Our procedures aim to reduce the toxic load, promote mitochondrial activity and regulate systemic inflammation – all factors that play an important role in the course of therapy.
How long does immunotherapy take? Time perspectives for patients
Many patients ask themselves: How long does immunotherapy actually last?
The answer to this is individual and depends on the type of tumor, the response to therapy and the general state of health. As a rule, immunotherapy extends over several months to a year – often in several cycles. This involves regular infusions or injections, sometimes supplemented by check-ups.
At VitaSangius, we accompany patients during this time with supportive measures to keep the body stable and resilient during the long treatment phase. This not only increases tolerance, but may also prolong the effectiveness of the therapy.
Immunotherapy for metastases: Hope despite advanced disease
Immunotherapy for metastases offers new hope to many patients – even in situations where curative treatment no longer seems possible. Modern immunotherapies can specifically influence tumor activity even in the metastatic stage and slow down the progression of the disease. However, it is crucial that the immune system does not collapse under this strain.
VitaSangius supports immunotherapy for metastases through therapeutic relief, systemic milieu regulation and targeted strengthening of the immune functions. In this way, the quality of life can be improved and the therapy goal – stabilization of the disease for as long as possible – can be effectively supported.
The role of regeneration and self-healing
A central goal of VitaSangius is to bring the body into a state in which self-healing is possible again. This can be crucial, particularly in the case of advanced illnesses or resistance to therapy – e.g. immunotherapy for metastases or difficult-to-treat cases such as immunotherapy for lung cancer. Supporting cancer immunotherapy through targeted relief, mitochondrial activation and milieu regulation is not a substitute, but a useful addition – in close coordination with the oncology specialists treating the patient and under medical supervision in our practice.
Better quality of life, better resilience
Patients often report that they feel better, have more energy and cope better with immunotherapy side effects thanks to the accompanying measures at VitaSangius. Even in palliative situations, the concept of cancer immunotherapy can maintain and support quality of life when conventional therapies have been exhausted. In addition, initial clinical experience reports show that by relieving the immune system, immunotherapy can improve the chances of success and reduce relapse rates.
Why the combination counts
Cancer immunotherapy opens up new horizons in oncology. However, its effectiveness depends crucially on the patient’s internal environment. VitaSangius creates the conditions for the immune system to better fulfill its task again. Individual blood cleansing, micronutrient infusions and a comprehensive view of the entire organism create an effective symbiosis – of modern conventional medicine and integrative complementary therapy. The question “How long does immunotherapy last?” is also rethought in the overall context: the more stable the immune system, the more lasting the effect can be – even beyond the acute therapy period.
Conclusion on immunotherapy for cancer
Immunotherapy for cancer opens up new opportunities – but it can only develop its full potential if the body can work together holistically. This is precisely where VitaSangius comes in: with a well thought-out, individually tailored concept that specifically relieves, strengthens and regulates the immune system. Whether for immunotherapy for lung cancer, immunotherapy for metastases or to improve the tolerability of accompanying chemotherapy – our procedures create the conditions for greater effectiveness, fewer side effects and a better quality of life.
For people who expect more than the standard – and want medical support that sees the whole person.
Feel free to contact us here – we will take the time to answer your questions and advise you individually.
